Show simple item record

Long term follow-up of a phase 2 study examining intratumoral G100 alone and in combination with pembrolizumab in patients with follicular lymphoma

dc.contributor.authorFlowers, R
dc.contributor.authorPanizo, C
dc.contributor.authorIsufi, I
dc.contributor.authorHerrera, F
dc.contributor.authorOkada, C
dc.contributor.authorCull, H
dc.contributor.authorKis, B
dc.contributor.authorChaves, M
dc.contributor.authorBartlett, L
dc.contributor.authorAi, Y
dc.contributor.authorCruz-Merino, L
dc.contributor.authorBryan, J
dc.contributor.authorHouot, R
dc.contributor.authorLinton, Kim M
dc.contributor.authorBriones, J
dc.contributor.authorChau, I
dc.contributor.authorvon Keudell, R
dc.contributor.authorLu, L
dc.contributor.authorHsu, J
dc.contributor.authorHalwani, S
dc.date.accessioned2019-03-29T14:22:32Z
dc.date.available2019-03-29T14:22:32Z
dc.date.issued2018en
dc.identifier.citationFlowers C, Panizo C, Isufi I, Herrera A, Okada C, Cull E, et al.Long term follow-up of a phase 2 study examining Intratumoral G100 alone and in combination with pembrolizumab in patients with follicular lymphoma. Blood. 2018;132.en
dc.identifier.doi10.1182/blood-2018-99-117932en
dc.identifier.urihttp://hdl.handle.net/10541/621674
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1182/blood-2018-99-117932en
dc.titleLong term follow-up of a phase 2 study examining intratumoral G100 alone and in combination with pembrolizumab in patients with follicular lymphomaen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchesteren
dc.identifier.journalBlooden
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record